MA H4986Introducedas of 2026-01-28
Relative to therapeutic psilocybin treatment centers
Plain-English summary
What happened: A Massachusetts bill relating to therapeutic psilocybin treatment centers has had its reporting deadline extended to December 31, 2026.
Why it matters: The extended timeline delays the establishment of any regulatory framework for psilocybin treatment centers, prolonging uncertainty for businesses and patients anticipating a legal market.
Affects: retailers and patients
LATEST ACTION: Reporting date extended to Thursday, December 31, 2026
READ THE FULL BILL TEXT βFollow Massachusetts cannabis bills for free. One plain-English email a week with every bill that moved, including this one.
Get the free digestMore Massachusetts cannabis bills
H5403REPORT of the SPECIAL JOINT COMMITTEE on INITIATIVE PETITIONS on the INITIATIVE PETITION of ANGIE AN-CHI TSO
AND OTHERS FOR THE PASSAGE OF AN ACT TO RESTORE A SENSIBLE MARIJUANA POLICY (see House, No. 5002).IntroducedH5350Modernizing the commonwealthβs cannabis lawsPassedS2985Order relative to authorizing the joint committee on Cannabis Policy to make an investigation and study of certain current Senate documents relative to enable private donations to the cannabis social equity trust fund.IntroducedH5002To restore a sensible marijuana policyIntroducedS2800Regulating the sale of hemp products to protect public healthIntroducedS2889Order relative to authorizing the joint committee on Cannabis Policy to make an investigation and study of a certain current Senate document relative to host community agreements.IntroducedS2816Order relative to authorizing the joint committee on Cannabis Policy, to make an investigation and study of certain current Senate documents relative to insurance and treatment matters.IntroducedS2817Order relative to authorizing the joint committee on Cannabis Policy, to make an investigation and study of certain current Senate documents relative to cannabis policy matters.Introduced
ALL MASSACHUSETTSCANNABIS LAWS & BILLS βLegislative data via LegiScan, licensed under CC BY 4.0. Summaries and categorization by CannaSignal. Regulatory information, not legal advice.